Open AccessPrEPping for a healthier future – a concise update of current pharmacological HIV-prophylaxis practices
Author(s) -
Stephan Steyn,
De Wet Wolmarans,
Linda Brand
Publication year - 2020
Publication title -
south african general practitioner
Language(s) - English
Resource type - Journals
eISSN - 2706-9621
pISSN - 2706-9613
DOI - 10.36303/sagp.2020.2.0015
Subject(s) - human immunodeficiency virus (hiv) , medicine , pre exposure prophylaxis , safer sex , intensive care medicine , immunology , virology , men who have sex with men , family medicine , syphilis , condom
Pre-exposure prophylaxis (PrEP) refers to the use of antiretroviral drugs to prevent one from acquiring human immunodeficiency virus (HIV) infection when engaging in high-risk sexual behaviour. Adequate PrEP initiation is key in the clinical outcome and survival of not only vulnerable and high-risk populations, but also to ensure that a society which is free of HIV, is built.